Day One Biopharmaceuticals I Share Price

NASDAQ: DAWN

Small Cap

$7.00

-0.12

(-1.62%)

as on September 18, 2025 at 1:29 am IST

$₹

Day One Biopharmaceuticals I Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$6.96
Day's Price Range
$7.27
$7
0.57%
Downside
3.86%
Upside
52 Week's Low
52 Week's High
$5.64
52-Week Price Range
$16.76
$7
19.50%
Downside
139.43%
Upside

Day One Biopharmaceuticals I share price movements today

Previous Close: $7.11
Open: $7.11
Volume: 918.9K
Day's Low - High: $6.96 - $7.27
52 Week Low - High: $5.64 - $16.76

Day One Biopharmaceuticals I Historical Returns

1 Month Return: + 5.33 %
3 Month Return: + 9.38 %
1 Year Return: -48.33 %
3 Year Return: -66.99 %
5 Year Return: 0 %

Day One Biopharmaceuticals I Stock Fundamentals & Key Indicators

Check Day One Biopharmaceuticals I market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$735.5M

EPS (TTM)

-1.1707

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-108.8M

Revenue (TTM)

187.6M

Profit Margin

-50.63%

Return On Equity TTM

36365500.00%

Day One Biopharmaceuticals I vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Day One Biopharmaceuticals I with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Day One Biopharmaceuticals I	BUY	$735.5M	NA	NA	-50.63%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Day One Biopharmaceuticals I Stock including INR - Dollar returns

The Day One Biopharmaceuticals I stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Day One Biopharmaceuticals I investment value today

Current value as on today

₹55,470

Returns

₹44,530

(-44.53%)

Returns from Day One Biopharmaceuticals I Stock

₹49,128 (-49.13%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Day One Biopharmaceuticals I Stock

Based on 17 analysts

BUY

82.35%

Buy

11.76%

Hold

5.88%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Day One Biopharmaceuticals I. Average target price of $24.25

Day One Biopharmaceuticals I Share Price Target

Get share price movements and forecasts by analysts on Day One Biopharmaceuticals I.

What analysts predicted

71.13%UPSIDE

Target Price

$24.25

Current Price

Analyzed by

17 Analysts

Target

$24.25

Day One Biopharmaceuticals I target price $24.25, a slight upside of 71.13% compared to current price of $7. According to 17 analysts rating.

Day One Biopharmaceuticals I Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	8	93	29	30	33
Gross Profit	0	0	0	0	0	7	92	26	27	30
Operating Income	-45	-49	-51	-59	-66	-114	29	-65	-41	-34
EBITDA	-45	-49	-51	-59	-66	-114	29	-64	-40	-34
Interest Expense	3	-	-	3	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-42	-45	-46	-54	-62	-2	36	-59	-35	-30
Income Tax Expense	-7	-3	0	10	0	1	0	6	-	-
Net Income	-35	-45	-46	-54	-62	-4	37	-65	-35	-30
Net Profit Margin	0.00%	0.00%	0.00%	-9734.11%	0.00%	-53.80%	39.50%	-224.99%	-117.02%	-89.42%

Day One Biopharmaceuticals I Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	131
Gross Profit	-	0	0	0	0	125
Operating Income	-14	-13	-72	-146	-206	-217
EBITDA	0	-43	-72	-146	-206	-217
Interest Expense	2	0	0	4	-	-
Depreciation	-	0	0	0	0	2
Income Before Tax	-16	-43	-72	-142	-188	-88
Income Tax Expense	-2	-3	-2	-10	-	-7
Net Income	-14	-40	-70	-132	-188	-95
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-72.81%

Day One Biopharmaceuticals I Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-45	-46	-54	-62	-4	37	-65	-35	-30
Operating Cash Flow	-42	-37	-41	-49	-49	50	-30	-58	-24
Investing Cash Flow	20	88	30	89	17	-67	-269	-32	26
Financing Cash Flow	162	0	0	0	1	200	1	-	0
Change in Cash	139	51	-10	39	-30	183	-297	-91	2

Day One Biopharmaceuticals I Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-43	-72	-142	-188	-95
Operating Cash Flow	-13	-48	-109	-146	-78
Investing Cash Flow	0	-8	-255	128	-230
Financing Cash Flow	29	297	165	163	203
Change in Cash	16	240	-199	145	-105

Global Institutional Holdings in Day One Biopharmaceuticals I

Funds	Holdings
FMR Inc	13.38%
BlackRock Inc	6.6%
Vanguard Group Inc	5.8%
RA Capital Management, LLC	5.62%
Alyeska Investment Group, L.P.	3.96%

See all

Insights on Day One Biopharmaceuticals I

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 117.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 183.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, DAWN stock has moved down by -3.5%

About Day One Biopharmaceuticals I

day one biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. we are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unparalleled ability to advance promising discoveries for patients of any age. we are ready to pursue the full potential of our therapies to improve the greatest number of lives as quickly as possible.

Organisation	Day One Biopharmaceuticals I
Headquarters	1800 Sierra Point Parkway, Brisbane, CA, United States, 94005
Industry	Healthcare
CEO	Dr. Jeremy Bender M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of Day One Biopharmaceuticals I

Name	Title
Mr. John Stubenrauch Ph.D.	Chief Technology Officer
Dr. Davy Chiodin Ph.D., Pharm.D.	Chief Development Officer
Dr. Jeremy Bender M.B.A., Ph.D.	CEO, President & Director
Mr. Adam Dubow J.D.	General Counsel, Chief Compliance Officer & Secretary
Ms. Jaa Roberson	Chief People Officer
Ms. Lauren Merendino M.B.A.	Chief Commercial Officer
Dr. Elly Barry M.D.	Chief Medical Officer
Dr. Michael J. Vasconcelles M.D., Ph.D.	Head of Research & Development
Mr. Charles N. York II, M.B.A.	COO & CFO
Mr. Joey Perrone	Senior Vice President of Finance & Investor Relations

FAQs

What is Day One Biopharmaceuticals I share price today?

Day One Biopharmaceuticals I share price today is $7 as on September 18, 2025 at 1:29 am IST at the close of the market. Day One Biopharmaceuticals I share today touched a day high of $7.27 and a low of $6.96.

What is the 52 week high and 52 week low for Day One Biopharmaceuticals I share?

Day One Biopharmaceuticals I share touched a 52 week high of $16.76 on November 8, 2024 and a 52 week low of $5.64 on August 6, 2025. Day One Biopharmaceuticals I stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $7,which is 58.23% down from its 52 week high and 24.22% up from its 52 week low.

What is Day One Biopharmaceuticals I's market capitalisation today?

Day One Biopharmaceuticals I market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Day One Biopharmaceuticals I Stock (DAWN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Day One Biopharmaceuticals I on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Day One Biopharmaceuticals I Shares that will get you 0.2143 shares as per Day One Biopharmaceuticals I share price of $7 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Day One Biopharmaceuticals I Stock (DAWN) from India?

Indian investors can start investing in Day One Biopharmaceuticals I (DAWN) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 10:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Day One Biopharmaceuticals I stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 10:41 am IST). Based on Day One Biopharmaceuticals I share’s latest price of $7 as on September 18, 2025 at 1:29 am IST, you will get 1.4286 shares of Day One Biopharmaceuticals I. Learn more about fractional shares .